Page 1 of Clinical Trials for "Palivizumab", 21 Total Matches
- 1CompletedLast Updated: March 22, 2012Condition(s): Respiratory Syncytial Virus Infection
- 2CompletedLast Updated: January 7, 2010Condition(s): Chronic Lung Disease
- 3CompletedLast Updated: June 21, 2011Condition(s): Respiratory Syncytial Virus Infection; Premature Birth; Bronchopulmonary Dysplasia; Congenital Heart Disease
- 4RecruitingLast Updated: February 16, 2012Condition(s): Respiratory Syncytial Virus Infections
- 5CompletedLast Updated: May 14, 2012Condition(s): Respiratory Syncytial Virus Infection
- 6CompletedLast Updated: February 14, 2012Condition(s): Congenital Heart Disease
- 7CompletedLast Updated: November 12, 2010Condition(s): -Unhealthy Children With a History of Prematurity
- 8CompletedLast Updated: March 18, 2011Condition(s): Severe Respiratory Syncytial Virus Infection
- 9CompletedLast Updated: January 19, 2012Condition(s): Premature Infants
- 10CompletedLast Updated: April 1, 2012Condition(s): Recurrent Wheezing; Wheezing; Asthma
- 11CompletedLast Updated: March 31, 2010Condition(s): Cancer
- 12Not yet recruitingLast Updated: May 29, 2011Condition(s): Airway Hyperreactivity and Lower Respiratory Morbidity After Palivizumab in Premature Babies (30-32 Weeks)
- 13Active, not recruitingLast Updated: November 22, 2011Condition(s): Prematurity
- 14RecruitingLast Updated: May 15, 2012Condition(s): Respiratory Syncytial Virus Infection
- 15CompletedLast Updated: December 27, 2007Condition(s): Healthy
- 16CompletedLast Updated: May 27, 2008Condition(s): Pain From Intramuscular Palivizumab Injection
- 17CompletedStudy of Motavizumab (MEDI-524) and Palivizumab in the Same Respiratory Syncytial Virus (RSV) SeasonLast Updated: April 20, 2010Condition(s): Respiratory Syncytial Virus Infections; Chronic Lung Disease
- 18Active, not recruitingLast Updated: March 5, 2012Condition(s): Atopic Asthma; Recurrent Wheezing
- 19RecruitingLast Updated: February 17, 2012Condition(s): Respiratory Syncytial Virus Infection
- 20RecruitingLast Updated: May 24, 2012Condition(s): Lower Respiratory Tract Infection; Respiratory Syncytial Virus Infections
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Palivizumab%22
